Beta-arrestin 2

Beta-arrestin 2
National Center for Biotechnology Information, U.S. National Library of Medicine · Public domain · source
Name	Beta-arrestin 2
Uniprot	P32121
Organism	Homo sapiens
Gene	ARRB2
Length	~418 aa

Beta-arrestin 2 is a multifunctional adaptor and scaffold protein involved in the regulation of G protein-coupled receptors and diverse intracellular signaling networks. Discovered in the context of adrenergic receptor desensitization, it has been characterized through biochemical, genetic, and structural studies and investigated in models ranging from yeast to human tissues. Its roles intersect with pharmacology, cell biology, and clinical research, linking receptor trafficking to disease mechanisms and therapeutic modulation.

Structure and Biochemistry

Beta-arrestin 2 is a ~418–amino-acid protein encoded by the ARRB2 gene and adopts a two-domain architecture with an N-terminal and C-terminal domain separated by a polar core. Structural studies using X-ray crystallography and cryo-electron microscopy in complexes with receptor phosphopeptides and antibodies have elucidated conformational states relevant to interaction with receptors and effectors; these analyses were conducted in laboratories associated with institutions such as Harvard University, Max Planck Society, and Scripps Research. Post-translational modifications including phosphorylation, ubiquitination, and SUMOylation modulate its activity and were characterized in work from groups at National Institutes of Health, University of California, San Francisco, and University of Cambridge. Conserved residues critical for phosphate sensing and receptor binding were identified through comparative studies involving model organisms like Saccharomyces cerevisiae and Caenorhabditis elegans as well as mammalian systems studied at centers such as Massachusetts Institute of Technology and Stanford University.

Mechanism of Action

Beta-arrestin 2 binds phosphorylated carboxyl-terminal tails of activated G protein-coupled receptors, sterically preventing further G protein coupling and promoting receptor internalization via clathrin-coated pits. This mechanism was delineated in seminal experiments using receptors studied at institutions including Columbia University, Yale University, and University of Oxford, and involves interactions with adaptor proteins such as AP2 and with components of the endocytic machinery characterized in studies from European Molecular Biology Laboratory and Cold Spring Harbor Laboratory. Beyond desensitization, beta-arrestin 2 acts as a scaffold that organizes signaling complexes including kinases such as MAPKs and Src family kinases; these scaffolding functions were demonstrated in biochemical assays and cellular imaging performed at Johns Hopkins University and University College London. Conformational switching between inactive and active states, revealed by collaborations among groups at Rigel Pharmaceuticals and academic labs, underlies its ability to discriminate among receptor phosphorylation patterns and to direct distinct cellular outcomes.

Cellular Functions and Signaling Pathways

In cells, beta-arrestin 2 regulates receptor endocytosis, trafficking to endosomes, recycling or degradation, and directs non-canonical signaling cascades including ERK, JNK, and p38 MAPK pathways. Functional mapping studies connecting beta-arrestin 2 to pathways were reported in consortia involving National Center for Biotechnology Information, European Bioinformatics Institute, and major universities such as University of Chicago and University of Pennsylvania. It interfaces with small GTPases and cytoskeletal regulators, influencing cell migration and morphology in models used by laboratories at University of Cambridge, Imperial College London, and University of Tokyo. Beta-arrestin 2-dependent scaffolds modulate transcriptional responses through interactions with transcriptional regulators and chromatin-associated factors profiled in projects at Broad Institute and Cold Spring Harbor Laboratory.

Physiological Roles and Tissue Distribution

Beta-arrestin 2 is broadly expressed across mammalian tissues, with high levels reported in brain regions including cortex and hippocampus, in heart, lung, liver, and immune cells; tissue distribution patterns were cataloged in atlases produced by Human Protein Atlas, Allen Institute for Brain Science, and surveys from National Institutes of Health. In the nervous system, it influences synaptic plasticity and neurotransmitter receptor regulation studied at neurobiology centers such as Salk Institute and Max Planck Institute for Brain Research, while in cardiovascular and pulmonary contexts it modulates responses to adrenergic and angiotensin receptors investigated at Cleveland Clinic and Mayo Clinic. Immune and inflammatory roles have been explored in collaborations with institutions like University of California, Los Angeles and Karolinska Institutet, linking beta-arrestin 2 to chemokine receptor function and leukocyte trafficking.

Involvement in Disease and Therapeutic Implications

Delta or dysregulation of beta-arrestin 2 signaling has been implicated in cardiovascular disease, neurodegeneration, cancer, and psychiatric disorders, with translational research carried out by consortia including National Cancer Institute, National Institute of Mental Health, and academic hospitals such as Massachusetts General Hospital. Biased agonism at G protein-coupled receptors that favors beta-arrestin 2 pathways offers therapeutic opportunities for drugs targeting pain, heart failure, and psychiatric conditions; pharmaceutical efforts by companies like Pfizer, GlaxoSmithKline, and AstraZeneca have pursued ligands exploiting this bias. Genetic and proteomic studies linking ARRB2 variants and expression changes to disease phenotypes were reported in cohorts assembled by UK Biobank, Framingham Heart Study, and collaborative projects at European Molecular Biology Laboratory.

Experimental Methods and Research Tools

Research on beta-arrestin 2 employs biochemical pull-downs, co-immunoprecipitation, fluorescence resonance energy transfer, bioluminescence resonance energy transfer, cryo-EM, X-ray crystallography, mass spectrometry, and live-cell imaging; major method developments have been contributed by laboratories at Stanford University, University of Oxford, and Massachusetts Institute of Technology. Genetic tools include ARRB2 knockout mice produced in facilities such as Jackson Laboratory and transgenic models characterized at National Institutes of Health, along with CRISPR/Cas9 editing applied in cell lines from repositories like ATCC. Small-molecule probes and biased ligands used to dissect function are available from academic–industry collaborations involving NIH Chemical Genomics Center and pharmaceutical partners, while databases and bioinformatics resources hosted by UniProt, Gene Ontology Consortium, and Ensembl support integrative analyses.

Category:Proteins Category:Signal transduction proteins